With the number of cancer cases steadily rising in India, there has never been a greater need for accessible treatment options. Indian Council of Medical Research (ICMR) statistics show that more than 14 lakh new cases of cancer were reported in 2023, and 100 out of every 1 lakh people are diagnosed with cancer every year. In this light, health experts have hailed the recent government decision to waive basic customs duty on 17 essential cancer drugs as a ray of hope for cancer patients.
According to Dr Arun Kumar Giri, Director – Surgical Oncology from Aakash Healthcare, “Although the budget announcement is important, it is only when patients feel the difference in their lives that the real difference will be felt. Pharmacies and hospitals are already adjusting prices, and patients are hoping that the benefits will soon reach them.”
Dr Puneet Gupta, Chairman- Oncology Services, from Asian Hospital said, “This week also marks World Cancer Day, which is observed under the theme ‘United by Unique’ and emphasises the significance of personalised, patient-centric care.” “When patients can access medicines without delay or financial stress, their recovery chances improve significantly.”
Dr Gupta explained. “This policy change allows hospitals to plan treatments more effectively and ensures that critical therapies reach those who need them most.”
He also said that the burden of cancer treatment is also growing in rural areas and small towns, and a large number of people may not have access to insurance. These steps, including increasing detection and treatment facilities in government hospitals, can go a long way in controlling the disease and saving lives.
Dr Jaipalreddy, Consultant – Surgical Oncology, Jupiter Hospital Pune, said that the budget announcement is part of a bigger push to strengthen healthcare access in India. “Along with these exemptions, investments in regional healthcare hubs and training of caregivers will make cancer care more efficient.”
Dr Jaipalreddy said. “Patients will not only get affordable medicines but also better support throughout their treatment journey.”
Dr Vineet Malhotra, Head of Urology and, Director at VNA Hospital, highlighted how the price cuts affect specialised care. “Certain cancer treatments require imported or rare drugs that were previously very expensive,”
Dr Malhotra said. “Reducing import duties makes these therapies affordable and ensures patients receive the right treatment on time. It is a major step in easing both financial and health burdens.”
Dr Giri said that the budget announcement to cut prices for life-saving cancer drugs is very much in line with the aim of providing patient-focused and accessible cancer treatment, offering hope and relief to thousands of patients across India. For families battling cancer, it is more than just a policy changeit is a chance for better care and a more secure future, he added.
Meanwhile, financial experts say the government’s move may also have positive effects on health insurance coverage. “With lower drug prices, insurance companies may find it easier to cover treatment costs, reducing out-of-pocket expenses for patients,” said Dr Giri. Policyholders who previously had to pay high co-pays for imported or specialty drugs may now benefit from broader coverage and fewer claim rejections. This may encourage more patients to seek timely treatment without financial burden, he said.